AI-generated analysis. Always verify with the original filing.
NovaBay Pharmaceuticals, Inc. filed a second amended and restated Certificate of Incorporation on March 12, 2026, and held a Special Meeting of stockholders on the same date where matters were submitted to a vote. Exhibit 3.1 contains the amended certificate.
Event Type
Disclosure
Mandatory
Variant
8-K
. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On March 12, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) filed a second amen
. Submission of Matters to a Vote of Security Holders. On March 12, 2026, the Company held the Special Meeting. The following matters were submitted to a vote
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 3.1 Second Amended and Restated Certificate of Incorporation. 104 Cover Page Interacti